期刊文献+

哌仑西平抑制豚鼠形觉剥夺性近视的视网膜机制 被引量:3

Mechanism of pirenzepine on form deprivation myopia in guinea pigs
原文传递
导出
摘要 目的观察哌仑西平对豚鼠形觉剥夺性近视的抑制效果,探讨其可能的作用机制。方法 1周龄豚鼠60只随机分为4组,每组15只,分别为正常对照组(Ⅰ组)、单纯遮盖组(Ⅱ组)、哌仑西平组(Ⅲ组)与氯化钠组(Ⅳ组);各组右眼为观察眼,左眼为对照眼。6周后检测4组豚鼠双眼屈光度、眼轴长度,免疫组织化学法及Western blot检测视网膜多巴胺转运蛋白(dopamine transporter,DAT)的表达水平,并进行统计分析。结果Ⅱ,Ⅳ组观察眼相对屈光度及眼轴长度变化与Ⅰ组比较差异有统计学意义(P<0.05),Ⅲ组与Ⅰ组比较差异无统计学意义(P>0.05);视网膜DAT阳性细胞数和DAT蛋白表达Ⅱ,Ⅳ组明显低于Ⅰ,Ⅲ组(P<0.05),Ⅰ组与Ⅲ组,Ⅱ组与Ⅳ组比较差异均无统计学意义(P>0.05)。结论哌仑西平能抑制豚鼠形觉剥夺性近视的发展,阻止近视视网膜DAT表达水平下降,推测哌仑西平可能通过影响视网膜多巴胺系统而抑制近视的发展。 Objective To observe the effect of pirenzepine on inhibiting form deprivation myopia (FDM) in guinea pigs and to study its mechanism. Methods A total of 60 one-week-old guinea pigs were randomly divided into 4 groups: group I (normal controls), group II (form-deprivation), group III (pirenzepine solution), and group IV (sodium chloride). FDM was established in the right eyes of each guinea pig. The left eyes served as control eyes. Ocular refraction and axial length were measured 6 weeks later. Immunohistochemistry and Western blot were used to analyze the expression of retinal dopamine transporter (DAT). These data were statistically analyzed. Results There were significant differences in refractive error and axial length between group I and II , and between group I and IV (P〈0.05), and there were no significant differences between group I and III (P〉0.05). The count of DAT positive cells and DAT protein level were lower in group II and IV than those in group I and III (P〈 0.05). There were no significant differences between group I and II , and between group II and IV (P〉0.05). Conclusion Pirenzepine can prevent the development of FDM, and inhibit the decrease of DAT expression. It is indicated that pirenzepine may block the development of FDM by influencing dopamine transporter system.
出处 《中华实用诊断与治疗杂志》 2012年第10期951-954,共4页 Journal of Chinese Practical Diagnosis and Therapy
关键词 形觉剥夺性近视 哌仑西平 多巴胺转运蛋白 豚鼠 Form deprivation myopia pirenzepine dopamine transporter guinea pig
  • 相关文献

参考文献5

二级参考文献29

  • 1LEQi-hua,CHENGNeng-neng,WUWei,CHURen-yuan.Effects of pirenzepine ophthalmic solution on form-deprivation myopia in the guinea pigs[J].Chinese Medical Journal,2005(7):561-566. 被引量:11
  • 2吉红云,李春霞,汪芳润.哌仑西平抑制实验性近视眼的研究进展[J].眼科新进展,2005,25(5):461-463. 被引量:1
  • 3王楷迪,张金嵩,闫磐石.不同配方哌仑西平滴眼液的兔角膜通透性的实验研究[J].中华眼科杂志,2006,42(6):531-534. 被引量:6
  • 4Stone RA,Lin T,Laties AM.Muscarinic antagonist effects on experimental chick myopia.Exp Eye Res,1991,52:755-758.
  • 5Cottriall CL,McBrien NA.The Mi muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew.Invest Ophthalmol Vis Sci,1996,37:1368-1379.
  • 6Siatkowski R.Pirenzepine 2% ophthalmic gel retards myopic progression in 8-12 year old children.Invest Ophthalmol Vis Sci,2003,44:4778.
  • 7Bartlett JD,Niemann K,Houde B,et al.Safety and tolerability of pirenzepine ophthalmic gel in pediatric myopia patients.Invest Ophthalmol Vis Sci,2000,41 (suppl):303.
  • 8Stoughton RB,McClure WD.Azone:a new non toxic enhancer of percutaneous penetration.Drug Dev Ind Pharm,1983,9:725-744.
  • 9Tang-liu DD,Richman JB,Weinkam R J,et al.Effect of four penetration enhancers on corneal permeability of drugs in vitro.J Pharm Sci,1994,83:85-90.
  • 10Cottriall CL,McBrien NA,Annies R,et al.Prevention of formdeprivation myopia with pirenzepine:a study of drug delivery and distribution.Ophthalmic Physiol Opt,1999,19:327-335.

共引文献48

同被引文献91

  • 1史煜,陈春生,钱益勇,吴昌凡,曾骏文.哌仑西平抑制近视眼机制的研究[J].眼科研究,2007,25(6):446-449. 被引量:4
  • 2Morgan IG, Ohno-Matsui K, Saw SM. Myopia[ J]. Lancet,2012,379 : 1739-1748.
  • 3McBrien NA, Jobling AI, Truong HT, et al. Expression of muscarinic receptor subtypes in tree shrew ocular tissues and their regulation during the development of myopia[ J]. Mol Vis ,2009,15 : 464-475.
  • 4Liu Q, Wu J, Wang X, et al. Changes in muscarinic acetylcholine receptor expression in form deprivation myopia in guinea pigs [ J ]. Mol Vis ,2007,13 : 1234-1244.
  • 5McBrien NA, Cottriall CL, Annies R. Retinal acetylcholine content in normal and myopic eyes:a role in ocular growth control? [ J]. Vis Neurosci ,2001,18 : 571-580.
  • 6Vessey KA, Cottriall CL, McBrien NA. Muscarinic receptor protein expression in the ocular tissues of the chick during normal and myopic eye development[ J]. Brain Res Dev Brain Res,2002,135:79-86.
  • 7Tigges M,Tigges J,Rees H, et ah Distribution of muscarinic cholinergic receptor proteins ml to m4 in area 17 of normal and monocularly deprived rhesus monkeys[ J]. J Comp Neurol, 1997,388 : 130-145.
  • 8Tong L, Huang XL, Koh AL, et al. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine [ J ]. Ophthalmology ,2009,116 : 572- 579.
  • 9Chia A, Chua WH, Cheung YB, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5% , 0.1% , and 0.01% doses ( Atropine for the Treatment of Myopia 2 ) [ J ]. Ophthalmology, 2012.119 : 347-354.
  • 10Fischer AJ, McKinnon LA, Nathanson NM, et al. Identification and localization of muscarinic acetylcholine receptors in the ocular tissues of the chick[ J]. J Comp Neurol,1998,392:273-284.

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部